Dana-Farber Research News 12.15.2025 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Dana-Farber Research News 12.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from November 16 - 30.

  • December 15, 2025

  • 19 min

Share

  • 1

    Dana-Farber's Research News highlights recent publications by faculty, focusing on research from November 16-30, 2025.

  • 2

    Hemophagocytic lymphohistiocytosis (HLH) is a severe condition requiring early recognition and intervention to prevent organ damage and death.

  • 3

    Loss of PTEN promotes tumorigenesis through a mechanism involving PI3K? phosphorylation, creating a target for therapy in PTEN-deficient cancers.

  • 4

    BAX, a pro-apoptotic protein, is inhibited by a dimer of BCL-w, revealing a new layer of apoptotic control through protein interactions.

  • 5

    The PINES trial found that eltrombopag significantly improved platelet response in children with newly diagnosed immune thrombocytopenia.

Original Source(s)

Dana-Farber Research News 12.15.2025

  • December 15, 2025

Related Content

Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments)

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

  • by

  • September 24, 2026

  • 11 min
Safety-Oriented Benchmarking of Large Language Models in Risk-Based Management of Abnormal Cervical Screening Results: Scenario-Based Benchmark Study